Cardiovascular Biomarkers Pathophysiology and Disease Management /
So rapidly has the number of cardiac assays available grown, and then improved, that current biomarkers not only diagnose cardiovascular disease, but also frame treatment strategies. In Cardiovascular Biomarkers: Pathophysiology and Disease Management, a distinguished panel of internationally recogn...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Totowa, NJ :
Humana Press,
2006.
|
| Σειρά: | Contemporary Cardiology
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Biomarkers of Necrosis
- Biomarkers of Myocardial Necrosis
- Analytical Issues for Clinical Use of Cardiac Troponin
- Defining Myocardial Infarction
- Biomarkers in the Emergency Department
- Cardiac Troponin for Risk Assessment and Management of Non-ST-Elevation Acute Coronary Syndrome
- Biomarkers of Necrosis for Risk Assessment and Management of ST-Elevation Myocardial Infarction
- Cardiac Troponin After Revascularization Procedures
- Biomarkers of Necrosis in Heart Failure
- Is There a Role for Cardiac Troponin and Other Biomarkers in Patients With Pulmonary Embolism?
- Cardiac Troponin in Conditions Other Than Acute Coronary Syndromes
- Degradation of Cardiac Troponins
- Biomarkers of Ischemia
- Developing a Marker of Ischemia
- Emerging Biomarkers of Myocardial Ischemia
- Biomarkers of Inflammation
- Inflammation in Cardiovascular Disease
- Analytic Issues for Clinical Use of C-Reactive Protein
- C-Reactive Protein as a Tool for Risk Assessment in Primary Prevention
- High-Sensitivity C-Reactive Protein for Risk Assessment in Acute Coronary Syndromes
- Beyond C-Reactive Protein
- Biomarkers of Inflammation
- Biomarkers of Infection and Risk of Coronary Heart Disease
- Biomarkers of Hemodynamic Stress
- Biology of Natriuretic Peptides
- Analytic Issues for Clinical Use of B-Type Natriuretic Peptide and N-Terminal Pro B-Type Natriuretic Peptide
- Clinical Use of Natriuretic Peptides for the Diagnosis and Management of Heart Failure
- Natriuretic Peptides in Acute and Chronic Coronary Artery Disease
- Novel Markers of Hemodynamic Stress
- Biomarkers of Platelet Function and Hemostasis
- Clinical and Research Applications of Markers of Thrombosis
- Measures of Platelet Activation and Aggregation
- Monocyte-Platelet Aggregates in Patients With Ischemic Heart Disease
- Biomarkers of Dyslipidemia and Lipid Modification
- Measurement of Atherogenic Lipoproteins in Cardiovascular Risk Assessment
- Lipoprotein-Associated Phospholipase A2 and Other Lipid-Related Biomarkers in Cardiovascular Disease
- Contemporary and Future Applications of Biomarkers in clinical care
- A Multimarker Approach to Evaluation of Patients With Acute Coronary Syndrome
- Cardiac Biomarkers by Point-of-Care Testing
- Proteomics and Discovery of Cardiovascular Biomarkers
- Genetic Markers in Cardiovascular Disease.
